AI-enhanced virtual histology utilizing optical coherence tomography to assess acute and short-term efficacy of bioresorbable scaffolds versus drug-eluting stents - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

AI-enhanced virtual histology utilizing optical coherence tomography to assess acute and short-term efficacy of bioresorbable scaffolds versus drug-eluting stents

  • By

  • Chengpeng Liu

  • Jiasheng Yin

  • Yaojun Zhang

  • Chenguang Li

  • Hao Lu

  • Gang Zhao

  • Juying Qian

  • Yizhe Wu

  • Li Shen

  • Junbo Ge

  • March 10, 2026

Share

Clinical Scorecard: AI-enhanced virtual histology utilizing optical coherence tomography to assess acute and short-term efficacy of bioresorbable scaffolds versus drug-eluting stents

At a Glance

CategoryDetail
ConditionPercutaneous coronary intervention (PCI)
Key Mechanisms
Target Population
Care Setting

Key Highlights

  • BRS designed to promote positive vascular remodeling but associated with higher thrombosis rates
  • Optimized implantation strategy (PSP) improves clinical outcomes for BRS
  • Study compares acute performance of BRS and DES using OCT imaging
  • Correlations found between stent deployment parameters and adverse events
  • AI-driven OCT analysis enhances diagnostic accuracy and reproducibility
  • Ethical guidelines and informed consent are critical in patient enrollment.

Guideline-Based Recommendations

Diagnosis

  • Utilize OCT for assessing stent deployment and expansion parameters

Management

  • Implement PSP strategy for BRS to enhance outcomes

Monitoring & Follow-up

  • Conduct post-PCI OCT imaging to evaluate plaque and stent characteristics
  • Monitor for scaffold thrombosis related to stent strut thickness and deployment issues

Risks

  • Monitor for scaffold thrombosis related to stent strut thickness and deployment issues

Patient & Prescribing Data

Patients with lesions less than 30 mm in length and reference vessel diameters of 2.75 to 3.5 mm

Pre-procedure medication includes 0.3 g Aspirin and 300 mg Clopidogrel; Bivalirudin for high bleeding risk patients

Clinical Best Practices

  • Ensure optimal stent sizing and expansion during deployment
  • Adhere to ethical guidelines and obtain informed consent
  • Utilize AI-driven OCT for enhanced analysis of vascular and plaque components
  • Monitor for scaffold thrombosis post-PCI.

Related Resources & Content

Original Source(s)

AI-enhanced virtual histology utilizing optical coherence tomography to assess acute and short-term efficacy of bioresorbable scaffolds versus drug-eluting stents

  • by Chengpeng Liu, Jiasheng Yin, Yaojun Zhang, Chenguang Li, Hao Lu, Gang Zhao, Juying Qian, Yizhe Wu, Li Shen, Junbo Ge

  • March 10, 2026

Related Content

Lactate Biomarker May Predict Outcomes in Cardiogenic Shock

A review of cardiogenic shock studies suggests serial lactate measurements provide more prognostic information than isolated values and may better reflect treatment response.

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Error in Author Contributions

  • July 1, 2026